A Glimpse Into Tomorrow's Cures: Anixa Biosciences Prepares for a Revealing Fireside Chat
The RNA Gamble: Avidity Biosciences Faces Its Next Big Test
Taysha Gene Therapies Stock Takes a Dive: Unpacking the Impact of Their Latest Public Offering
Eupraxia Pharmaceuticals Secures $70 Million Through Public Offering to Accelerate Osteoarthritis Treatment Development
Adial Pharmaceuticals Soars: FDA's Positive Feedback Fuels Hope for Groundbreaking AUD Treatment
Harbour BioMed Welcomes Dr. Yajie Li as New Chief Medical Officer